{"id":49615,"date":"2024-07-01T00:01:16","date_gmt":"2024-07-01T04:01:16","guid":{"rendered":"https:\/\/reviewofmm.com\/?p=49615"},"modified":"2024-06-26T14:12:44","modified_gmt":"2024-06-26T18:12:44","slug":"systemic-melatonin-and-myopia-is-there-a-causal-link","status":"publish","type":"post","link":"https:\/\/reviewofmm.com\/systemic-melatonin-and-myopia-is-there-a-causal-link\/","title":{"rendered":"Systemic Melatonin and Myopia: Is There a Causal Link?"},"content":{"rendered":"
July 1, 2024<\/strong><\/p>\n By Nicole Liu, MOptm, PhD Candidate, Brien Holden Vision Institute<\/strong><\/p>\n \u00a0Photo Credit: Getty Images<\/em><\/span><\/p>\n<\/div>\n Melatonin is an ancient molecule that originated as a free radical scavenger and evolved in bacteria, later becoming integral to eukaryotic life through symbiotic associations.<\/span>1<\/span><\/sup> In humans, melatonin is primarily produced by the pineal gland in response to the light-dark cycle, regulating sleep, circadian rhythms<\/a><\/strong>, immunity, and oxidative stress.<\/span>2<\/span><\/sup> Its secretion peaks at night and varies with seasons, reflecting photoperiod changes and influencing biological and behavioral functions, with levels highest in early childhood and decreasing with age.<\/span>3,4<\/span><\/sup> Positive effects of melatonin and its analogs in treating various ocular conditions such as dry eye and cataract have been frequently reported in studies using animal models.<\/span>5-8<\/span><\/sup> In humans, melatonin and its analogs also demonstrated beneficial impact in lowering intraocular pressure, treating glaucoma, and improving age-related macular degeneration.<\/span>9<\/span><\/sup>\u00a0<\/span><\/p>\n Interest in the role of melatonin in myopia has been growing recently, yet findings are inconsistent.<\/span>10<\/span><\/sup> Thus, Hussain et al.<\/span>11<\/span><\/sup> conducted a systematic review critically summarizing and analyzing current literature on systemic levels of melatonin and myopia, aiming to enhance our understanding of this relationship.<\/span>\u00a0<\/span><\/p>\n Seven cross-sectional studies published between January 2010 and December 2022 were reviewed, including sample sizes ranging from 18 to 120 participants aged between 5 and 41 years. Two studies examined serum melatonin, three examined saliva, and two examined both saliva and urine or serum. Various analytical methods were employed, including liquid chromatography-mass spectrometry, enzyme-linked immunosorbent assay, and double antibody radioimmunoassay. Results are conflicting: three studies reported elevated melatonin concentrations in myopes,<\/span>12-14<\/span><\/sup> one study noted a significantly lower overnight urinary melatonin output and delayed melatonin circadian timing in myopes compared to emmetropes.<\/span>15<\/span><\/sup> In contrast, other studies found no difference in the timing\/phase or concentration between refractive groups.<\/span>13,16,17<\/span><\/sup><\/p>\n The authors concluded that future studies with larger cohorts, robust methodological approaches, longitudinal designs, and standardized methodologies are essential to elucidate melatonin’s potential role in myopia development.<\/span><\/p>\n <\/p>\n Abstract<\/strong><\/p>\n Associations Between Systemic Melatonin and Human Myopia: A Systematic Review<\/strong><\/p>\n Azfira Hussain, Aparna Gopalakrishnan, Hannah Scott, Chris Seby, Victoria Tang, Lisa Ostrin, Ranjay Chakraborty<\/span><\/p>\n Purpose:<\/strong> Experimental models have implicated the role of melatonin circadian rhythm disruption in refractive error development. Recent studies have examined melatonin concentration and its diurnal patterns on refractive error with equivocal results. This systematic review aimed to summarize the literature on melatonin circadian rhythms in myopia.<\/span><\/p>\n Recent findings:<\/strong> PubMed, EMBASE, Web of Science, Scopus, ProQuest Central, LILACS, Cochrane, and Medline databases were searched for papers between January 2010 and December 2022 using defined search terms. Seven studies measured melatonin and circadian rhythms in three biological fluids (blood serum, saliva, and urine) in both myopes and non-myopes. Morning melatonin concentrations derived from blood serum varied significantly between studies in individuals aged 10-30 years, with a maximum of 89.45 pg\/mL and a minimum of 5.43 pg\/mL using liquid chromatography and mass spectrometry. The diurnal variation of salivary melatonin was not significantly different between myopes and emmetropes when measured every 4 h for 24 h and quantified with enzyme-linked immunosorbent assay. Significantly elevated salivary melatonin concentrations were reported in myopes compared with emmetropes aged 18-30 years when measured hourly from evening until their habitual bedtime using liquid chromatography. However, the relationship between dim light melatonin onset and refractive group was inconsistent between studies. The 6-sulphatoxymelatonin concentration derived from overnight urine volume, measured using a double antibody radioimmunoassay, was found to be significantly lower in myopes (29.17 pg\/mL) than emmetropes (42.51 pg\/mL).<\/span><\/p>\n Summary:<\/strong> The role of melatonin concentration and rhythm in myopia has not been studied extensively. This systematic review confirms conflicting findings across studies, with potential relationships existing. Future studies with uniform methodological approaches are required to ascertain the causal relationship between melatonin dysregulation and myopia in humans.<\/span><\/p>\n Hussain, A., Gopalakrishnan, A., Scott, H., Seby, C., Tang, V., Ostrin, L., & Chakraborty, R. (2023). Associations between systemic melatonin and human myopia: a systematic review. <\/span>Ophthalmic and Physiological Optics<\/span><\/i>, <\/span>43<\/span><\/i>(6), 1478-1490. <\/span><\/p>\n DOI:<\/span>https:\/\/doi.org\/10.1111\/opo.13214<\/a><\/strong><\/p>\n <\/p>\n<\/a><\/p>\n